A Study to Investigate the Safety and Effectiveness of SAR448851 in Participants With Early Alzheimer's Disease

NCT07688213 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

160

Enrollment

INDUSTRY

Sponsor class

Conditions

Dementia, Alzheimer's Type
Alzheimer's Disease

Interventions

DRUG: SAR448851
DRUG: Placebo

Sponsor

Sanofi